Concord Biotech Ltd. Investor Presentation

Pursuant to Regulation 30 of SEBI(LODR)Regulations, 2015 Investor Presentation on financial results for the second quarter and half year ended 30th September,2024 is enclosed. Kindly take note the records

pdf

Concord Biotech Ltd.

10 Aug 2024

1866.80

-0.49%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, Investor Presentation on financial results for the first quarter ended June 30, 2024, is enclosed Kindly take the above on records

pdf

Concord Biotech Ltd.

27 May 2024

1866.80

-0.49%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to regulation 30 of schedule III Part A (LODR) regulation 2015, Investor Presentation on financial results for the fourth quarter and year ended March 31, 2024 is enclosed. Kindly take the above on records.

pdf

Concord Biotech Ltd.

09 Feb 2024

1866.80

-0.49%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Schedule III Part A of SEBI (LODR) Regulations, 2015, "investors presentation" on the financial results for the Third Quarter and Nine months ended December 31, 2023 is enclosed.

pdf

Concord Biotech Ltd.

08 Nov 2023

1866.80

-0.49%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to regulation 30 of Schedule III Part A of SEBI (Listing Obligations and disclosure requirements) Regulations, 2015, investors presentation on financial results for the quarter and half year ended on September 30, 2023 is enclosed.

pdf

Concord Biotech Ltd.

06 Sep 2023

1866.80

-0.49%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, a results presentation to analyst/investor for the period ended June 30, 2023 is enclosed. Kindly take the above on records.

pdf

Concord Biotech Ltd. Investor Presentation

Concord Biotech Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more